Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA

Showing 15 posts of 1444 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …

News
merckentranceweb

FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections

July 18, 2019
Sales and Marketing FDA, MSD, Recarbrio, US, pharma, urinary tract

MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment …

News
Bayer image

Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients

July 16, 2019
Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma

The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.

News
ema_logo

FDA and EMA fully implement mutual recognition agreement between US and EU

July 15, 2019
Sales and Marketing EMA, FDA, GMP, Slovakia, mra, mutual recognition, pharma

The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties. The recognition of Slovakia marks the full …

News
astrazeneca_building_white

AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes

July 15, 2019
Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga

The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …

News
16792957331_d9572dbdf4_z

FDA sharpen focus on pharmaceutical companies under Trump

July 5, 2019
Medical Communications FDA, Obama, Trump, USA, pharma, regulation

The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …

News
dw-anzcxqaqavhl

FDA approves multiple myeloma therapy Xpovio despite safety concerns

July 4, 2019
Sales and Marketing FDA, Karyopharm, Xpovio, multiple myeloma, pharma

The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …

News

Elizabeth Warren calls on former FDA commissioner Scott Gottlieb to resign from board of Pfizer

July 2, 2019
Research and Development FDA, Pfizer, Scott Gottlieb, health, pharma, public health

Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer.   In a letter to Gottlieb, Senator Warren …

News
scott_gottlieb_getty_images

Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors

June 28, 2019
Medical Communications FDA, Pfizer, Scott Gottlieb, pharma

Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …

News
dw-anzcxqaqavhl

FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis

June 27, 2019
Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis

Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …

News

FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris

June 25, 2019
Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma

Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …

News
vertex-headquarters

FDA expands Vertex’s cystic fibrosis drug Symdeko in paediatric patients

June 24, 2019
Sales and Marketing FDA, Symdeko, Vertex, cystic fibrosis, pharma

Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko …

News
16792957331_d9572dbdf4_z

FDA approve libido enhancing drug for women with low sexual desire

June 24, 2019
Sales and Marketing FDA, HSDD, health, pharma, viagra, vyleesi

The FDA has approved a new drug for women with low libido.The FDA has approved AMAG Pharmaceuticals’ bremelanotide – sold …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten

It’s Friday, and time for another run-down of the week’s most popular articles.

News
merck-keytruda

MSD’s Keytruda snatches up first approval in small cell lung cancer

June 19, 2019
Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma

MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026